| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Anti-influenza monoclonal antibody (AIMM Therapeutics) | Phase 1 Clinical | Aimm Therapeutics | Influenza, Human | Details | |
| cH8/1N1 LAIV | Phase 1 Clinical | Icahn School Of Medicine At Mount Sinai | Influenza, Human | Details | |
| Ad4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases) | Phase 1 Clinical | Emergent Biosolutions Inc | Communicable Diseases | Details |